Orange Book product · Generic (ANDA)
LEVOCARNITINE
LEVOCARNITINE
At a glance
Oct 25, 2007
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 25, 2007
18 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
LEVOCARNITINE
Strength
1GM/10ML
Dosage form
SOLUTION
Route
ORAL
TE code
Not listed
Application
ANDA 077399
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LEVOCARNITINE
- 1992CARNITORBrand (NDA)
NDA 020182 · LEADIANT BIOSCI INC
- 1988CARNITORBrand (NDA)
NDA 018948 · LEADIANT BIOSCI INC
- 1986CARNITORBrand (NDA)
NDA 019257 · LEADIANT BIOSCI INC
- 2025LEVOCARNITINEGeneric (ANDA)
ANDA 217430 · DEVA HOLDING AS
- 2022LEVOCARNITINEGeneric (ANDA)
ANDA 216384 · NOVITIUM PHARMA
- 2021LEVOCARNITINEGeneric (ANDA)
ANDA 212533 · SCIEGEN PHARMS
- 2019LEVOCARNITINEGeneric (ANDA)
ANDA 211676 · NOVITIUM PHARMA
- 2004LEVOCARNITINEGeneric (ANDA)
ANDA 076858 · RISING
- 2004LEVOCARNITINEGeneric (ANDA)
ANDA 076851 · RISING
- 2001LEVOCARNITINEGeneric (ANDA)
ANDA 075861 · AM REGENT
- 2001LEVOCARNITINEGeneric (ANDA)
ANDA 075567 · HIKMA
- 2001LEVOCARNITINEGeneric (ANDA)
ANDA 075881 · TEVA PHARMS USA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
